Sir,

A 56-year-old man presented with a 1-month history of multiple, erythematous, annular plaques on his trunk \[[Figure 1a](#F1){ref-type="fig"}\] that appeared about 4 weeks after intranasal administration of desmopressin (40 mcg/daily) for diabetes insipidus, arose 24 hours after excision of a dopamine agonist-resistant prolactinoma performed about 2 months earlier. The man denied other drugs intake and health issues. Laboratory testing showed no alteration. Histopathological examination of one plaque revealed diffuse edema and interstitial infiltrate of lymphocytes and histiocytes in the upper dermis, with periadnexal involvement and vacuolar interface dermatitis \[[Figure 2a](#F2){ref-type="fig"}\]. CD68 stain confirmed the presence of histiocytes \[[Figure 2b](#F2){ref-type="fig"}\] and Masson\'s trichrome and Verhoeff\'s stains revealed collagen and elastic fibers fragmentation, respectively \[Figure [3a](#F3){ref-type="fig"} and [b](#F3){ref-type="fig"}\]. In the absence of collagen necrobiosis and vasculitic changes, a probable diagnosis of interstitial granulomatous drug eruption (IGDR) was hypothesized.

![Multiple, pruritic, erythematous, annular plaques on the trunk (a); recurrence of lesions after desmopressin rechallenge (b)](IJD-61-125a-g001){#F1}

![Hypogranulosis, spongiosis with lymphocytes exocytosis, dyskeratotic cells and a few apoptotic keratinocytes associated with diffuse edema and interstitial infiltrate of lymphocytes and some histiocytes in the upper dermis, with periadnexal involvement and vacuolar interface dermatitis (H and E, ×10) (a). Immunohistochemical staining for CD68 antigen confirms the presence of histiocytes (magnification ×10) (b)](IJD-61-125a-g002){#F2}

![Evidence of piecemeal fragmentation of collagen (a) (Masson\'s trichrome stain ×20) and elastic fibers (b) (Verhoeff\'s stain ×20)](IJD-61-125a-g003){#F3}

Since in most cases postoperative diabetes insipidus is transient,\[[@ref1]\] we suspended desmopressin. After 3 weeks, lesions almost completely regressed \[[Figure 1b](#F1){ref-type="fig"}\], without recurrence of diabetes insipidus. One month later, the patient underwent radiation for residual prolactinoma, resulting in recurrence of transient diabetes insipidus which required intranasal desmopressin re-administration; the same lesions reappeared after 3 weeks of therapy and regressed 2 weeks after stopping the drug, confirming diagnosis of IGDR. No recurrence was observed during the subsequent 2-month follow-up.

IGDR is an uncommon pattern of adverse reactions to medication presenting as erythematous/violaceous, asymptomatic or slightly pruritic, annular plaques with indurated border.\[[@ref2][@ref3]\] The most involved sites are the body folds, but it may also affect the trunk and extremities.\[[@ref2]\] Histologically, IGDR is characterized by diffuse interstitial infiltrate of lymphocytes and histiocytes with collagen and elastic fibers fragmentation and vacuolar interface dermatitis. Atypical lymphocytes and palisaded granulomas surrounding degenerated collagen may be present.\[[@ref3]\] Although the pathogenesis of IGDR is still not fully understood, the most recent theory suggests that it\'s the result of a cell-mediated immune response to drug-induced unknown dermal products and/or a disturbance in the degradation of collagen fibers responsible for interstitial granulomatous inflammation.\[[@ref4]\]

Several medications have been implicated, including calcium channel blockers, angiotensin-converting enzyme inhibitors, lipid-lowering agents, nonsteroidal anti-inflammatory drugs, TNF-alpha inhibitors, febuxostat and herbal medications.\[[@ref2][@ref3][@ref4]\] The latency period between drug intake and IGDR onset ranges from days to years;\[[@ref2]\] no specific treatment is required since it regresses with involved medication suspension.\[[@ref4]\] Differential diagnosis includes interstitial granuloma annulare, palisaded neutrophilic granulomatous dermatitis, and interstitial granulomatous dermatitis. Interstitial granuloma annulare and interstitial granulomatous dermatitis demonstrate complete collagen necrobiosis in contrast to IGDR. Leukocytoclastic vasculitis-like changes with neutrophils in early lesions and palisaded granulomas in developed lesions are characteristics of palisaded neutrophilic granulomatous dermatitis. The onset of IGDR shortly after intranasal desmopressin, associated with a recurrence of the manifestations after a rechallenge, would support a possible role of such drug in the induction of IGDR in our case.\[[@ref5]\] To our knowledge, this report is the first instance of a similar association and, based on our experience, we suggest that desmopressin should be included among the causative medications of IGDR.
